5 Best Beaten Down Stocks To Buy Now

2. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders: 66

A Buy rating and an $84 price target were reiterated on Bristol-Myers Squibb Company (NYSE:BMY) shares on September 15 by Gregg Gilbert at Truist Securities.

A total of 66 hedge funds were long Bristol-Myers Squibb Company (NYSE:BMY) in the second quarter, with a total stake value of $1.7 billion.

Bristol-Myers Squibb Company (NYSE:BMY) is a pharmaceutical company based in New York. It offers products for hematology, oncology, cardiovascular, and immunology diseases, among more.

Follow Bristol Myers Squibb Co (NYSE:BMY)